Clinical trials

Center for Phage Research and Phage Therapy, Regensburg, Germany

The PCR will participate in the PhagoDAIR trial, a randomized, non-comparative, double-blinded phase I/II clinical study using phage cocktails in patients with S. aureus periprosthetic-joint infections with indication for debridement, antibiotic and implant retention ( ID: NCT05369104) clinicaly executed at the department of trauma surgery (Director: Prof. Dr. Dr. Volker Alt).